A radiation detection technology company focusing on the medical, security screening and nuclear markets.
19-Dec-2017 – 27p – £70.3m – PER n/a
Interim Results For The 6 Months To End October 2017 – A little strange this one. Revenue is up27% to £4.8m (from £3.8m) and Gross Margin is up from 53% to 63%. Yet, Loss Before Tax is the same, -£1.8m. Cash stands at £15m.
No interest for me – Even forecasts, to double Revenue here by 2019, reflect an overall loss.
Advertisement
